GlassScriptPhysician profile
James B Colombo
NPI 1891750527
$2,842.65
in general payments reported to CMS, 2019-2025
30 companies · $1,132 in 2025
The $1,132 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $253 · 2020: $65.65 · 2021: $240 · 2022: $301 · 2023: $348 · 2024: $502 · 2025: $1,132.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,948 · Education: $35.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,947.96 |
| Education | $35.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dendreon Pharmaceuticals LLC | $633.79 | 2024-2025 | Provenge |
| Sumitomo Pharma America, INC. | $333.08 | 2023-2025 | Gemtesa, Orgovyx |
| Astellas Pharma US INC | $313.94 | 2019-2025 | Xtandi, Myrbetriq |
| Procept Biorobotics Corporation | $183.91 | 2019-2024 | Aquabeam System |
| Neotract INC. | $153.84 | 2019 | |
| Boston Scientific Corporation | $133.73 | 2019-2022 | |
| Progenics Pharmaceuticals, INC. | $101.31 | 2024-2025 | |
| Olympus America INC. | $98.01 | 2025 | Itind System |
| Janssen Biotech, INC. | $88.75 | 2019-2025 | Erleada, Akeega, Balversa |
| Medtronic, INC. | $88.40 | 2022-2023 | Interstim |
| Pfizer INC. | $82.97 | 2019-2025 | |
| Axonics, INC. | $55.12 | 2023 | Axonics |
| Antares Pharma, INC. | $54.09 | 2021-2025 | Xyosted |
| Abbvie INC. | $49.33 | 2023-2025 | Lupron Depot |
| Urogen Pharma, INC. | $48.38 | 2023-2025 | Jelmyto |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Verity Pharmaceuticals INC. | $46.24 | 2025 | Trelstar, Tlando |
| Ge Healthcare | $44.18 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $43.30 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $35.06 | 2025 | Imfinzi |
| Civco Medical Instruments | $32.35 | 2025 | |
| Endo Pharmaceuticals INC. | $30.98 | 2021 | |
| Ferring Pharmaceuticals INC. | $30.06 | 2019-2025 | Adstiladrin |
| Blue Earth Diagnostics | $27.24 | 2021 | |
| Calyxo, INC. | $26.30 | 2024 | Cvac Aspiration System |
| Merck Sharp & Dohme LLC | $25.42 | 2023 | Welireg, Keytruda, Lynparza |
| Accord Healthcare, INC. | $18.79 | 2025 | |
| Tolmar, INC. | $16.89 | 2024 | |
| Tolmar Pharmaceuticals, INC. | $16.27 | 2020 | |
| Urovant Sciences INC | $16.13 | 2022 | |
| Medtronic USA, INC. | $14.79 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Colombo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.